The effects of the traditional Chinese medicine, “Banxia Houpo Tang (Hange-Koboku To)” on the swallowing reflex in Parkinson's disease

Iwasaki, Katsunori; Wang, Q.; Seki, H.; Satoh, Kei; Takeda, Atsushi; Arai, Hiroyuki; Sasaki, Hidetada

doi:10.1016/s0944-7113(00)80042-2

Cited by 47 publications

(31 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some studies did not have an adequate method of randomization for referral to different intervention groups, e.g., Iwasaki et al [23] and Bushman et al [27] did not score pre-versus posttreatment blinded for the schedule of treatment [4,24,[26][27][28], nor did they have an adequate placebo or control population [7,15,17,22,[26][27][28][29]. Very often a control group receiving no therapy for dysphagia when in fact an indication for treatment is present is regarded as unethical and therefore usually not approved by any medical ethical committee.…”

Section: Methodologic Problemsmentioning

confidence: 99%

See 1 more Smart Citation

Effects of Therapy for Dysphagia in Parkinson’s Disease: Systematic Review

2008

View full text Add to dashboard Cite

This systematic review explores the effects of dysphagia treatment for Parkinson's disease. The review includes rehabilitative, surgical, pharmacologic, and other treatments. Only oropharyngeal dysphagia is selected for this literature search, excluding dysphagia due to esophageal or gastric disorders. The effects of deep brain stimulation on dysphagia are not included. In general, the literature concerning dysphagia treatment in Parkinson's disease is rather limited. Most effect studies show diverse methodologic problems. Multiple case studies and trials are identified by searching biomedical literature databases PubMed and Embase, and by hand-searching reference lists. The conclusions of most studies cannot be compared with one another because of heterogeneous therapy methods and outcome measures. Further research based on randomized controlled trials to determine the effectiveness of different therapies for dysphagia in Parkinson's disease is required.

show abstract

Section: Methodologic Problemsmentioning

confidence: 99%

“…The study by Iwasaki et al [23] described the positive therapy effects of traditional Chinese medicine ''Banxia Houpo Tang'' (BHT) in improving the swallowing reflex of patients with Parkinson's disease. They studied 28 patients with a defined H-Y score and compared them to five healthy controls of comparative age.…”

Section: Pharmacologic Treatmentmentioning

confidence: 99%

Effects of Therapy for Dysphagia in Parkinson’s Disease: Systematic Review

2008

View full text Add to dashboard Cite

show abstract

“…Traditional Chinese and Japanese formulas Plants Banxia Houpo Tang (Chinese) (Iwasaki et al, 2000) Pinellia a (Pinellia ternate Thunb. ): 6.0 g Hoelen a (Poria cocos Wolf): 3.0 g Magnolia (Magnolia obovata Thunb.…”

Section: Table 1 Examples Of Traditional Chinese and Japanese Formulamentioning

confidence: 99%

“…In China, a number of prescriptions containing Houpo are still in use in modern clinical practice (Yu et al, 2012). In Japan, two prescriptions containing Magnolia bark, HangeKoboku-To (Japanese name for Banxia Houpo Tang) (Iwasaki et al, 2000) and Saiboku-To (Table 1), are also still in use in modern clinical practice (Li N. et al, 2007;Lee et al, 2011).…”

Section: Introductionmentioning

confidence: 99%

Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents

Poivre

Duez

2017

J. Zhejiang Univ. Sci. B

112

View full text Add to dashboard Cite

Traditional Chinese herbal drugs have been used for thousands of years in Chinese pharmacopoeia. The bark of Magnolia officinalis Rehder & E. Wilson, known under the pinyin name "Houpo", has been traditionally used in Chinese and Japanese medicines for the treatment of anxiety, asthma, depression, gastrointestinal disorders, headache, and more. Moreover, Magnolia bark extract is a major constituent of currently marketed dietary supplements and cosmetic products. Much pharmacological activity has been reported for this herb and its major compounds, notably antioxidant, anti-inflammatory, antibiotic and antispasmodic effects. However, the mechanisms underlying this have not been elucidated and only a very few clinical trials have been published. In vitro and in vivo toxicity studies have also been published and indicate some intriguing features. The present review aims to summarize the literature on M. officinalis bark composition, utilisation, pharmacology, and safety.

show abstract

“…Magnolia bark has been extensively used as Chinese folklore medicine and is still in use in modern clinical practices [41,42,43,44,45]. Magnolia trees have striking features like their alluring flowers with fragrance, and petiolate leaves containing large stipules surround the stem and later fall, leaving a distinctive scar around the node; the wood of the tree is tough, light weight and easy to work, and is sought after by craftsmen [46].…”

Section: Introductionmentioning

confidence: 99%

Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer

Ranaware¹,

Banik

Deshpande³

et al. 2018

IJMS

138

View full text Add to dashboard Cite

The past few decades have witnessed widespread research to challenge carcinogenesis; however, it remains one of the most important health concerns with the worst prognosis and diagnosis. Increasing lines of evidence clearly show that the rate of cancer incidence will increase in future and will create global havoc, designating it as an epidemic. Conventional chemotherapeutics and treatment with synthetic disciplines are often associated with adverse side effects and development of chemoresistance. Thus, discovering novel economic and patient friendly drugs that are safe and efficacious is warranted. Several natural compounds have proved their potential against this dreadful disease so far. Magnolol is a hydroxylated biphenyl isolated from the root and stem bark of Magnolia tree. Magnolol can efficiently prevent or inhibit the growth of various cancers originating from different organs such as brain, breast, cervical, colon, liver, lung, prostate, skin, etc. Considering these perspectives, the current review primarily focuses on the fascinating role of magnolol against various types of cancers, and the source and chemistry of magnolol and the molecular mechanism underlying the targets of magnolol are discussed. This review proposes magnolol as a suitable candidate that can be appropriately designed and established into a potent anti-cancer drug.

show abstract

The effects of the traditional Chinese medicine, “Banxia Houpo Tang (Hange-Koboku To)” on the swallowing reflex in Parkinson's disease

Cited by 47 publications

References 16 publications

Effects of Therapy for Dysphagia in Parkinson’s Disease: Systematic Review

Effects of Therapy for Dysphagia in Parkinson’s Disease: Systematic Review

Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents

Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer

Contact Info

Product

Resources

About